Study examines effectiveness of mobile phone-based intervention to slow weight regain

NewsGuard 100/100 Score

A scalable, mobile phone-based intervention designed to slow weight regain after an initial weight loss had no significant effect on participants’ weight, according to a study published this week in PLOS Medicine by Falko Sniehotta from Newcastle University, UK and colleagues.

Credit: Marco Verch, Flickr

Obesity is a major contributor to preventable life-years lost worldwide and, while effective behavioral weight loss interventions are available, weight loss is often followed by weight regain. In the new study, researchers carried out a randomized controlled trial involving 288 people from North East England with obesity who had recently lost at least 5% of their bodyweight. The NULevel intervention consisted of a single face-to-face goal-setting meeting, self-monitoring, and personalized feedback on weight, diet, and physical activity via SMS text messages with embedded links. The control group received standard lifestyle advice via newsletter.

Overall, 264 participants completed the trial. Those participating in the intervention group weighed themselves more frequently and were more physically active. However, the mean weight gain over the 12 month study period was similar in the two groups, with an average of 1.8 kg (95% CI 0.5 to 3.1) gained in the intervention group and 1.8 kg (95% CI 0.6 to 3.0) gained in the control group. The data suggest that the intervention is unlikely to be considered cost-effective in its current form.

“We conclude that the incremental dose of the NULevel intervention over the active control condition might have been insufficient to affect weight outcomes,” the authors say. “This research should inform future intervention design decisions regarding delivery modality and intensity.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Melatonin shows promise in preventing obesity, study finds